<span style="color: #222222;">Centre has said that it plans to ramp up the production of Bharat Biotech's Covaxin from 1.5 crore doses to about 10 crore doses every month.</span><br />'' <span style="color: #222222;"> </span><br />'' <span style="color: #222222;">NITI Aayog member Dr VK Paul said, total production of Covaxin doses will be further scaled up to 13 crore doses a month when three public sector undertakings start manufacturing the vaccine.</span><br />'' <span style="color: #222222;"> </span><br />'' <span style="color: #222222;">Briefing media persons, he said that the government will look at more private players to scale up the production of Covaxin.</span><br />'' <span style="color: #222222;"> </span><br />'' <span style="color: #222222;">Haffkine Biopharmaceuticals in Mumbai, Indian Immunologicals in Hyderabad and Bulandshahr-based Bharat Immunologicals and Biologicals are the three public sector units that will manufacture Covaxin vaccine.</span><br />'' <span style="color: #222222;"> </span><br />'' <span style="color: #222222;">Dr Paul said, Bharat Biotech's vaccine technology is being shared with the three PSUs with a provision of 150-crore rupees funding to scale up production.</span><br />''  <br />